The oxidative mechanism of heparin interferes with radical production by glucose and reduces the degree of glycooxidative modifications on human serum albumin

European Journal of Biochemistry

Volumn 268, Issue 8, 2001, Pages 2193-2200

  Finotti, Paola ^a   Pagetta, Andrea ^a   Ashton, Tony ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF GLAMORGAN   (United Kingdom)

Author keywords

Glycation; Heparin; Oxidation; Protein structure; Serum albumin

Indexed keywords

GLUCOSE; HUMAN SERUM ALBUMIN; LOW MOLECULAR WEIGHT HEPARIN; TRYPSIN;

ARTICLE; DRUG EFFECT; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; FLUORESCENCE SPECTROSCOPY; GLYCATION; HUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN STRUCTURE; ULTRAVIOLET SPECTROSCOPY;

DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON SPIN RESONANCE SPECTROSCOPY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESTERASES; FREE RADICALS; GLUCOSE; HEPARIN; HUMANS; HYPERGLYCEMIA; NITROPHENOLS; OXYGEN; SERUM ALBUMIN; SPECTROPHOTOMETRY; TIME FACTORS; TRYPSIN;

EID: 0035002649     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2001.02134.x     Document Type: Article

References (51)

1. Diabetes, oxidative stress, and platelet activation
2. Protein glycation and oxidative stress in diabetes mellitus and ageing
3. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus
4. Protein oxidation in aging, disease, and oxidative stress
5. Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity
6. Nonenzymatic glycosylation-induced modifications of intact bovine kidney tubular basement membrane
7. Glucose modification of human serum albumin: A structural study
8. Carbohydrate binding specificity of monoclonal antibodies raised against lactose-protein Maillard adducts
9. Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline
10. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface
11. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins
12. Effect of advanced glycation end product-modified albumin on tissue factor expression by monocytes
13. Increased urinary albumin and retinol-binding protein in type I diabetes
14. Mutual interaction between glycation anti oxidation during non-enzymatic protein modification
15. Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation
16. Superoxide production from nonenzymatically glycated protein
17. The free radical theory of aging matures
18. Oxidation-reduction properties of methylglyoxal-modified protein in relation to free radical generation
19. Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-α-phenylnitrone
20. Antioxidants reverse the antiproliferative effect of high glucose and advanced glycosylation end products in cultured rat mesangial cells
21. Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetes
22. Alpha-phenyl-tert-butylnitrone (PBN) inhibits NFKB activation offering protection against chemically induced diabetes
23. Antioxidants in the serum of children with insulin-dependent diabetes mellitus
24. Copper (II)-induced conformational changes and protease resistance in recombinant and cellular PrP
25. Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation
26. Nonenzymatic glycosylation in vitro in bovine endothelial cells alters basic fibroblast growth factor activity
27. Effects of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus
28. Heparin-induced structural modifications and oxidative cleavage of human serum albumin in the absence and presence of glucose. Implications for transcapillary leakage of albumin in hyperglycaemia
29. Fructosamine: Structure, analysis, and clinical usefulness
30. Biphasic pattern of heparin-induced oxidative degradation of trypsin in the presence of glucose
31. Methods of structural analysis
32. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
33. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
34. Determination of carbonyl content in oxidatively modified proteins
35. Kinetics of unireactant enzymes
36. Effects of drug binding to the esterase activity of human serum albumin: Inhibition modes and binding sites of anionic drugs
37. Esterase-like activity of human serum albumin toward prodrug esters of nicotinic acid
38. Role of Arg-410 and Tyr-411 in human serum albumin for ligand binding and esterase-like activity
39. Alteration of plasma proteinase-antiproteinase system in type 1 diabetic patients. Influence of sex and relationship with metabolic control
40. Site-selective glycosylation of subtilisin Bacillus lentus causes dramatic increases in esterase activity
41. Nonenzymatic glycosylation of human serum albumin alters its conformation and function
42. Spectral methods of characterizing protein conformation and conformational changes
43. The principal site of non-enzymatic glycosylation of human serum albumin in vivo
44. Nonenzymatic glycosylation of albumin in vivo
45. Identification and partial purification of a (Na-K) ATPase stimulating serine protease from plasma of insulin-dependent diabetics
46. Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties
47. Atomic structure and chemistry of human serum albumin
48. The effect of complex-formation with polyanions on the redox properties of cytochrome c
49. Oxidative Modification of apolipoprotein E in human very-low-density lipoprotein and its inhibition by glycosaminoglycans
50. Oxidation of heparin-treated low-density lipoprotein by peroxidases
51. Glucans exhibit weak antioxidant activity but stimulate macrophage free radical activity